Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

European patent covers Bayer's new HMG-CoA reductase inhibitors

March 18, 1998

Lilly describes novel compounds for postmenopausal syndrome and related conditions

March 18, 1998

Indazole inhibitors of PDE IV and TNF from Pfizer

March 18, 1998

Lilly develops selective serotonergic agents

March 18, 1998

Sumitomo claims compounds for treating reperfusion injury

March 18, 1998

Ono's new MMP inhibitors

March 18, 1998

Novartis describes new thrombin inhibitors

March 17, 1998

Neuroprotective glutamate antagonists from Warner-Lambert

March 17, 1998

Glaxo Wellcome researches MMP inhibitors

March 17, 1998

Depsipeptides useful in dementia under evaluation at Nisshin Flour Milling

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...